The development and appraisal of a tool designed to find patients harmed by falsely labelled, falsified (counterfeit) medicines

BACKGROUND: Falsely labelled, falsified (counterfeit) medicines (FFCm’s) are produced or distributed illegally and can harm patients. Although the occurrence of FFCm’s is increasing in Europe, harm is rarely reported. The European Directorate for the Quality of Medicines & Health-Care (EDQM) has...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Health Serv Res
Main Authors: Anđelković, Marija, Björnsson, Einar, De Bono, Virgilio, Dikić, Nenad, Devue, Katleen, Ferlin, Daniel, Hanževački, Miroslav, Jónsdóttir, Freyja, Shakaryan, Mkrtich, Walser, Sabine
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477164/
https://ncbi.nlm.nih.gov/pubmed/28633634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12913-017-2235-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados